Cargando…
P1148: REAL WORLD DATA (RWD) AMONG FOLLICULAR LYMPHOMA (FL) PATIENTS IN GERMANY WITH AT LEAST TWO PRIOR LINES OF SYSTEMIC THERAPY AND COMPARISON WITH CLINICAL DATA FOR MOSUNETUZUMAB
| Autores principales: | , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430647/ http://dx.doi.org/10.1097/01.HS9.0000847460.08152.b3 |
| _version_ | 1784779828978778112 |
|---|---|
| author | Marschner, N. Hanselmann, J. McGough, S. Braun, S. Pfizler-Dempfle, S. Sandner, R. Mohm, J. Jaber, M. Hamm, D. Hamm, N. Jaenicke, M. Shewade, A. |
| author_facet | Marschner, N. Hanselmann, J. McGough, S. Braun, S. Pfizler-Dempfle, S. Sandner, R. Mohm, J. Jaber, M. Hamm, D. Hamm, N. Jaenicke, M. Shewade, A. |
| author_sort | Marschner, N. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9430647 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94306472022-08-31 P1148: REAL WORLD DATA (RWD) AMONG FOLLICULAR LYMPHOMA (FL) PATIENTS IN GERMANY WITH AT LEAST TWO PRIOR LINES OF SYSTEMIC THERAPY AND COMPARISON WITH CLINICAL DATA FOR MOSUNETUZUMAB Marschner, N. Hanselmann, J. McGough, S. Braun, S. Pfizler-Dempfle, S. Sandner, R. Mohm, J. Jaber, M. Hamm, D. Hamm, N. Jaenicke, M. Shewade, A. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430647/ http://dx.doi.org/10.1097/01.HS9.0000847460.08152.b3 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Marschner, N. Hanselmann, J. McGough, S. Braun, S. Pfizler-Dempfle, S. Sandner, R. Mohm, J. Jaber, M. Hamm, D. Hamm, N. Jaenicke, M. Shewade, A. P1148: REAL WORLD DATA (RWD) AMONG FOLLICULAR LYMPHOMA (FL) PATIENTS IN GERMANY WITH AT LEAST TWO PRIOR LINES OF SYSTEMIC THERAPY AND COMPARISON WITH CLINICAL DATA FOR MOSUNETUZUMAB |
| title | P1148: REAL WORLD DATA (RWD) AMONG FOLLICULAR LYMPHOMA (FL) PATIENTS IN GERMANY WITH AT LEAST TWO PRIOR LINES OF SYSTEMIC THERAPY AND COMPARISON WITH CLINICAL DATA FOR MOSUNETUZUMAB |
| title_full | P1148: REAL WORLD DATA (RWD) AMONG FOLLICULAR LYMPHOMA (FL) PATIENTS IN GERMANY WITH AT LEAST TWO PRIOR LINES OF SYSTEMIC THERAPY AND COMPARISON WITH CLINICAL DATA FOR MOSUNETUZUMAB |
| title_fullStr | P1148: REAL WORLD DATA (RWD) AMONG FOLLICULAR LYMPHOMA (FL) PATIENTS IN GERMANY WITH AT LEAST TWO PRIOR LINES OF SYSTEMIC THERAPY AND COMPARISON WITH CLINICAL DATA FOR MOSUNETUZUMAB |
| title_full_unstemmed | P1148: REAL WORLD DATA (RWD) AMONG FOLLICULAR LYMPHOMA (FL) PATIENTS IN GERMANY WITH AT LEAST TWO PRIOR LINES OF SYSTEMIC THERAPY AND COMPARISON WITH CLINICAL DATA FOR MOSUNETUZUMAB |
| title_short | P1148: REAL WORLD DATA (RWD) AMONG FOLLICULAR LYMPHOMA (FL) PATIENTS IN GERMANY WITH AT LEAST TWO PRIOR LINES OF SYSTEMIC THERAPY AND COMPARISON WITH CLINICAL DATA FOR MOSUNETUZUMAB |
| title_sort | p1148: real world data (rwd) among follicular lymphoma (fl) patients in germany with at least two prior lines of systemic therapy and comparison with clinical data for mosunetuzumab |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430647/ http://dx.doi.org/10.1097/01.HS9.0000847460.08152.b3 |
| work_keys_str_mv | AT marschnern p1148realworlddatarwdamongfollicularlymphomaflpatientsingermanywithatleasttwopriorlinesofsystemictherapyandcomparisonwithclinicaldataformosunetuzumab AT hanselmannj p1148realworlddatarwdamongfollicularlymphomaflpatientsingermanywithatleasttwopriorlinesofsystemictherapyandcomparisonwithclinicaldataformosunetuzumab AT mcgoughs p1148realworlddatarwdamongfollicularlymphomaflpatientsingermanywithatleasttwopriorlinesofsystemictherapyandcomparisonwithclinicaldataformosunetuzumab AT brauns p1148realworlddatarwdamongfollicularlymphomaflpatientsingermanywithatleasttwopriorlinesofsystemictherapyandcomparisonwithclinicaldataformosunetuzumab AT pfizlerdempfles p1148realworlddatarwdamongfollicularlymphomaflpatientsingermanywithatleasttwopriorlinesofsystemictherapyandcomparisonwithclinicaldataformosunetuzumab AT sandnerr p1148realworlddatarwdamongfollicularlymphomaflpatientsingermanywithatleasttwopriorlinesofsystemictherapyandcomparisonwithclinicaldataformosunetuzumab AT mohmj p1148realworlddatarwdamongfollicularlymphomaflpatientsingermanywithatleasttwopriorlinesofsystemictherapyandcomparisonwithclinicaldataformosunetuzumab AT jaberm p1148realworlddatarwdamongfollicularlymphomaflpatientsingermanywithatleasttwopriorlinesofsystemictherapyandcomparisonwithclinicaldataformosunetuzumab AT hammd p1148realworlddatarwdamongfollicularlymphomaflpatientsingermanywithatleasttwopriorlinesofsystemictherapyandcomparisonwithclinicaldataformosunetuzumab AT hammn p1148realworlddatarwdamongfollicularlymphomaflpatientsingermanywithatleasttwopriorlinesofsystemictherapyandcomparisonwithclinicaldataformosunetuzumab AT jaenickem p1148realworlddatarwdamongfollicularlymphomaflpatientsingermanywithatleasttwopriorlinesofsystemictherapyandcomparisonwithclinicaldataformosunetuzumab AT shewadea p1148realworlddatarwdamongfollicularlymphomaflpatientsingermanywithatleasttwopriorlinesofsystemictherapyandcomparisonwithclinicaldataformosunetuzumab |